Pharmaceutical Technology on MSN2d
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US Food and Drug Administration (FDA) has approved scPharmaceuticals’ supplemental new drug application (sNDA) for ...
BMJ9d
MRI bone marrow oedema precedes lumbar bone stress injury diagnosis in junior elite cricket fast bowlers
The repetitive loading of cricket fast bowling may cause bone marrow oedema (BMO), detectable on MRI, before the bowler suffers from symptomatic bone stress injury. We investigated the temporal ...
Yahoo Finance27d
Regeneron’s macular oedema therapy shows promise in Phase III trial
Regeneron Pharmaceuticals has reported positive outcomes from the Phase III QUASAR trial of Eylea HD (aflibercept) 8mg injection in treating individuals with macular oedema following retinal vein ...